AbstractPsoriasis is a chronic, noncontiguous, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. There is a genetic predisposition to psoriasis and has tendency to wax and wane with flares related to systemic or environmental factors, including life stress events and infection.Majority of patients with psoriasis have limited disease (5% body surface area involvement) and can be treated with topical agents, which generally provide a high efficacy-to-safety ratio.To optimize the topical treatment of psoriasis in Saudi Arabia, the Saudi Society of Dermatology and Dermatologic surgery (SSDDS) have initiated a project to develop guidelines for the management of psoria...
The purpose of these Guidelines is to summarize the most relevant features of the pathogenesis, clin...
Since its inception, the Psoriasis Group (GPs) of the Spanish Academy of Dermatology and Venereology...
This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed fo...
AbstractPsoriasis is a chronic, noncontiguous, inflammatory, multisystem disease with predominantly ...
Psoriasis vulgaris is a common and chronic inflammatory skin disease which has the potential to sign...
Background Psoriasis is a chronic, relapsing, immune-mediated, potentially devastating disease, infl...
Psoriasis is a chronic multisystem inflammatory disease affecting primarily the skin and joints and ...
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psorias...
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psorias...
Background: Clinical practice guidelines (CPGs) developed with rigorous methods can help optimize cl...
The overall aim of the guideline is to provide up‐to‐date, evidence‐based recommendations on the use...
The overall aim of the guideline is to provide evidence-based recommendations on the use of biologic...
This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed fo...
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, ...
Psoriasis is a genetically determined, systemic immune-mediated chronic inflammatory disease that af...
The purpose of these Guidelines is to summarize the most relevant features of the pathogenesis, clin...
Since its inception, the Psoriasis Group (GPs) of the Spanish Academy of Dermatology and Venereology...
This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed fo...
AbstractPsoriasis is a chronic, noncontiguous, inflammatory, multisystem disease with predominantly ...
Psoriasis vulgaris is a common and chronic inflammatory skin disease which has the potential to sign...
Background Psoriasis is a chronic, relapsing, immune-mediated, potentially devastating disease, infl...
Psoriasis is a chronic multisystem inflammatory disease affecting primarily the skin and joints and ...
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psorias...
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psorias...
Background: Clinical practice guidelines (CPGs) developed with rigorous methods can help optimize cl...
The overall aim of the guideline is to provide up‐to‐date, evidence‐based recommendations on the use...
The overall aim of the guideline is to provide evidence-based recommendations on the use of biologic...
This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed fo...
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, ...
Psoriasis is a genetically determined, systemic immune-mediated chronic inflammatory disease that af...
The purpose of these Guidelines is to summarize the most relevant features of the pathogenesis, clin...
Since its inception, the Psoriasis Group (GPs) of the Spanish Academy of Dermatology and Venereology...
This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed fo...